Day: January 29, 2021

29 January 2021, Limassol, CyprusSeaBird Exploration Plc is pleased to announce its fourth quarter 2020 report.Headlines Q4 2020Revenues of $1.9 million, down from $7.6 million in Q4 2019Utilization of 29%, down from 42% in Q4 2019EBITDA negative $1.1 million, up from negative $5.5 million in Q4 2019EBITDA of $0.2 million in 2020 vs a loss of $5.6 million in 2019 despite utilization declining from 62% to 34%Awarded 2D contract in the Eastern Hemisphere with expected duration of 120 daysSigns of market recoveryCapitalizing and listing Green Minerals marks a change in strategy and a commitment to the energy transitionA complete rebranding of the Group will be presented to the AGM in MayThe company will host a webcast at 08:00 CET today. Please use the following link to join the webcast:https://teams.microsoft.com/l/meetup-join/19%3ameeting_ZDlkZjhiODgtNTQwOS00Y2RmLTgwMjItZGIzMzhhMTEwMjYz%40thread.v2/0?context=%7b%22Tid%22%3a%22d7181576-1d07-4383-b8ac-6451ab33feae%22%2c%22Oid%22%3a%22ab38ca4b-0069-4d66-b5ab-30f40647842e%22%2c%22IsBroadcastMeeting%22%3atrue%7dFor...

MONMOUTH JUNCTION, N.J., Jan. 28, 2021 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK) (“Outlook Therapeutics”), a late clinical-stage biopharmaceutical company working to develop the first FDA-approved ophthalmic formulation of bevacizumab-vikg for use in retinal indications, announced today that, due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 35,000,000 shares of common stock of Outlook Therapeutics, at a price to the public of $1.00 per share, less underwriting discounts and commissions. The closing of the offering is expected to occur on or about February 2, 2021, subject to satisfaction of customary closing conditions.H.C. Wainwright & Co. is acting as the sole book-running manager for the offering.Outlook Therapeutics...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Jan. 28, 2021 (GLOBE NEWSWIRE) — Global Care Capital Inc. (CSE:HLTH, FRANKFURT: L6V1) (the “Company” or “Global Care”) a global investment company which engages in early stage investment opportunities in private and public companies, is pleased to announce that further to its press release of January 21, 2021 it has now completed the acquisition of all of the issued and outstanding securities in the capital of ASIC Power Corporation (“ASIC”) pursuant to the terms of a share exchange agreement dated January 19, 2021 (the “Agreement”) among the Company, ASIC and the shareholders of ASIC (the “Transaction”). ASIC is the first cryptocurrency company combining state of the art ASIC chips with royalty streaming...

MALVERN, Pa., Jan. 28, 2021 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that it has priced the previously announced underwritten public offering of 4,840,000 shares of its common stock, at a public offering price of $15.50 per share. The Company has granted the underwriters a 30-day option to purchase up to an additional 726,000 shares of its common stock. The gross proceeds to the Company from this offering are expected to be approximately $75.0 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company. The offering is expected to close...

ANN ARBOR, Mich., Jan. 28, 2021 (GLOBE NEWSWIRE) — Home Point Capital Inc. (“Home Point Capital”), the parent entity of Homepoint, today announced the pricing of its initial public offering of 7,250,000 shares of its common stock at $13.00 per share. The shares are expected to begin trading on the NASDAQ Global Select Market on January 29, 2021 under the ticker symbol “HMPT,” and the offering is expected to close on February 2, 2021, subject to customary closing conditions. Home Point Capital is not selling any shares in the offering. In connection with the offering, the selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 1,087,500 shares of Home Point Capital’s common stock to cover over-allotments, if any.Home Point Capital will not receive any net proceeds from the sale of its common...

BOSTON, Mass., Jan. 28, 2021 (GLOBE NEWSWIRE) — Duck Creek Technologies, Inc. (Nasdaq: DCT) (“Duck Creek”), a provider of SaaS-delivered enterprise software to the property & casualty (“P&C”) insurance industry, announced today the pricing of an underwritten public offering by Duck Creek and certain of its stockholders of a total of 9,000,000 shares of Duck Creek’s common stock (an upsize of 1,000,000 shares) at a public offering price of $46.00 per share, including 8,910,000 shares offered by the selling stockholders and 90,000 shares offered by Duck Creek. The offering is expected to close on February 2, 2021, subject to customary closing conditions. The selling stockholders also granted the underwriters a 30-day option to purchase up to 1,350,000 additional shares of Duck Creek’s common stock at the public offering price,...

Hong Kong, Jan. 28, 2021 (GLOBE NEWSWIRE) — Bridgetown 2 Holdings Limited (the “Company”) today announced the closing of its initial public offering of 29,900,000 Class A ordinary shares, including the exercise in full of the underwriters 45-day option to purchase up to an additional 3,900,000 Class A ordinary shares. The offering was priced at $10.00 per share, resulting in gross proceeds of $299,000,000.Bridgetown 2 Holdings Limited is a blank check company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue a business combination target in any business or industry, the Company intends to focus on a target with operations or prospective operations in the technology, financial...

VANCOUVER, British Columbia, Jan. 28, 2021 (GLOBE NEWSWIRE) — VALOREM RESOURCES INC. (the “Company” or “Valorem”) (CSE: VALU) (Frankfurt: 1XW1) is pleased to announce that it has closed the first tranche of a non-brokered private placement (the “First Tranche”). Pursuant to the First Tranche, the Company issued 8,889,998 units (the “Units”) of the Company at a price of $0.10 per Unit for gross proceeds of $888,999.90 (the “Offering”).  Each Unit consists of one (1) common share of the Company (a “Common Share”) and one (1) transferable share purchase warrant (a “Warrant”). Each Warrant entitles the holder thereof to purchase one (1) additional Common Share for a period of one (1) year from closing at a price of $0.13 per Common Share.The securities issued pursuant to the First Tranche are subject to a four (4) month hold period....